Subcellular localization, modification and protein complex formation of the cdk-inhibitor p16 in Rb-functional and

Related Experiment Video

Updated: Aug 16, 2026

Analysis of Cell Cycle Position in Mammalian Cells
12:19

Analysis of Cell Cycle Position in Mammalian Cells

Published on: January 21, 2012

Kristina Nilsson1, Göran Landberg

  • 1Division of Pathology, Department of Laboratory Medicine, Lund University, Malmö University Hospital, S-205 02 Malmö, Sweden.

International Journal of Cancer
|September 15, 2005
PubMed

Insights

The tumor suppressor p16 (also known as CDKN2A) is found in both the nucleus and cytoplasm. Cytoplasmic p16 binds to cyclin-dependent kinase (cdk)4/6, suggesting a novel cytoplasmic function.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • The cyclin-dependent kinase inhibitor p16 is a crucial tumor suppressor gene frequently inactivated in various cancers.
  • Regulation of p16 expression is not fully understood, though retinoblastoma (Rb) protein status is a known influencing factor.
  • The subcellular localization of p16, particularly its presence in the cytoplasm, has been debated.

Purpose of the Study:

  • To investigate the subcellular localization and post-translational modifications of p16.
  • To explore the functional implications of p16's presence in different cellular compartments.
  • To determine if p16 interacts with cyclin-dependent kinases (cdks) in the cytoplasm.

Main Methods:

  • Subcellular fractionation of cell lines with functional and non-functional retinoblastoma (Rb) protein.
  • Two-dimensional gel electrophoresis to analyze p16 forms.
  • Analysis of skin cancer samples (basal cell carcinoma and squamous cell carcinoma) with varying Rb status.

Main Results:

  • p16 is confirmed to be expressed in both nuclear and cytoplasmic compartments.
  • Distinct post-translational modifications of p16 were observed in the cytoplasm versus the nucleus, with at least two forms detected in the cytoplasm and one in the nucleus.
  • Skin cancer samples also showed at least two forms of p16, irrespective of Rb functionality.
  • Cytoplasmic p16 was found to bind to cyclin-dependent kinase (cdk)4/6.

Conclusions:

  • p16 exhibits dual localization in the nucleus and cytoplasm, with differential post-translational modifications.
  • The binding of cytoplasmic p16 to cdk4/6 suggests a potential novel function for p16 outside the nucleus.
  • These findings contribute to a deeper understanding of p16 regulation and its role in tumorigenesis.

More Related Videos

In Vivo Detection and Analysis of Rb Protein SUMOylation in Human Cells09:40

In Vivo Detection and Analysis of Rb Protein SUMOylation in Human Cells

Published on: November 2, 2017

Spatio-Temporal Manipulation of Small GTPase Activity at Subcellular Level and on Timescale of Seconds in Living Cells10:27

Spatio-Temporal Manipulation of Small GTPase Activity at Subcellular Level and on Timescale of Seconds in Living Cells

Published on: March 9, 2012

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.